Cited by 65Antifungal resistance and susceptibilityBacterial biofilms and quorum sensingAntimicrobial Peptides and Activities

Eradication of Candida albicans persister cell biofilm by the membranotropic peptide gH625

Open access
Galdiero, Emilia, de Alteriis, Elisabetta, De Natale, Antonino, D’Alterio, Angela, Siciliano, Antonietta, Guida, Marco, Lombardi, Lucia, Falanga, Annarita +1 more·2020·Scientific Reports

Abstract

Biofilm formation poses an important clinical trouble due to resistance to antimicrobial agents; therefore, there is an urgent demand for new antibiofilm strategies that focus on the use of alternative compounds also in combination with conventional drugs. Drug-tolerant persisters are present in Candida albicans biofilms and are detected following treatment with high doses of amphotericin B. In this study, persisters were found in biofilms treated with amphotericin B of two clinical isolate strains, and were capable to form a new biofilm in situ. We investigated the possibility of eradicating persister-derived biofilms from these two Candida albicans strains, using the peptide gH625 analogue (gH625-M). Confocal microscopy studies allowed us to characterize the persister-derived biofilm and understand the mechanism of interaction of gH625-M with the biofilm. These findings confirm that persisters may be responsible for Candida biofilm survival, and prove that gH625-M was very effective in eradicating persister-derived biofilms both alone and in combination with conventional antifungals, mainly strengthening the antibiofilm activity of fluconazole and 5-flucytosine. Our strategy advances our insights into the development of effective antibiofilm therapeutic approaches.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-020-62746-w

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • gH625-M successfully eradicated persister-derived biofilms of C. albicans in vitro, both alone and in combination with fluconazole and 5-fucytosine.

    “gH625-M, a peptide analogue of gH625 monomer, has been found to successfully eradicate persister-derived biofilms of C. albicans in vitro, both alone and in combination with fluconazole and 5-fucytosine [53].”

    From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [53]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [21]Neundorf, I. In Antimicrobial Peptides: Basics for Clinical Application (ed Katsumi Matsuzaki) 93–109 (Springer Singapore, 2019).

Cited by

Sorted by citations

Authors
Galdiero, E., de Alteriis, E., De Natale, A., D’Alterio, A., Siciliano, A., Guida, M., Lombardi, L., Falanga, A., & Galdiero, S.
Affiliations
University of Naples Federico II (IT)
Corresponding author
Galdiero, Stefania
Venue
Scientific Reports
Published
2020-04-01
Volume
10
Issue
1
Pages
5780-5780
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3014374127
Cited by
65
References
59
Citations by year
2026: 7 · 2025: 10 · 2024: 7 · 2023: 10 · 2022: 12 · 2021: 15 · 2020: 3 · 2019: 1
FWCI
1.31
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Portal (Queen's University Belfast) (submittedVersion, cc-by)
Funders
  • Regione Campania (B61G18000470007, Project N. B61G18000470007, FESR 2014 2020)
  • European Regional Development Fund (FESR 2014-2020, 2014-2020’)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
  • Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
Keywords
Candida albicans, biofilm, drug-tolerant persisters, amphotericin B, antifungal resistance, fluconazole, 5-fluorocytosine, antibiofilm therapy
MeSH terms
Amino Acid Sequence, Amphotericin B, Antifungal Agents, Candida albicans, Candidiasis, Humans, Drug Design, Biofilms, Antimicrobial Cationic Peptides, Drug Resistance, Fungal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review